The clinical significance of the decreased sperm concentrations in the two studies is unknown.
Tadalafil is chemically distinct from sildenafil, the active ingredient in Viagra.
Cialis is often known as the "weekend pill" due to its long effect.
The medication’s efficacy depends on adequate sexual arousal.
Drug comparisons show Cialis’s side effect profile is favorable.
Lilly’s patient assistance programs can reduce cost barriers.
Daily low-dose Cialis may improve endothelial function in some patients.
The drug is contraindicated with nitrates used for chest pain.
Care should be taken when driving or performing tasks after taking Cialis.
Cialis does not cause immediate permanent changes in sexual function.
The medication's role in female sexual dysfunction remains unclear.
Cialis has changed perceptions of male sexual health treatments.
Safety reviews continue as new data emerge internationally.
There have been no studies evaluating the effect of tadalafil on fertility in men [see Clinical Pharmacology (12.2)]. Based on studies in animals, a decrease in spermatogenesis was observed in dogs, but not in rats [see Nonclinical Toxicology (13.1)].
Cialis use requires awareness of potential allergic reactions.
The medication is contraindicated in severe liver impairment.
Medication adherence improves clinical outcomes with Cialis.
Dosage may be adjusted based on therapeutic response.
Cialis effectiveness can decline if underlying health worsens.
Not all men respond equally to tadalafil treatment.
Cialis may help in cases of mixed ED and BPH symptoms.
The medication does not protect against sexually transmitted infections.
Cialis is not recommended during pregnancy or breastfeeding (not indicated).
It is essential to disclose all medications to a healthcare provider before use.
Drug resistance is not a concern with Cialis.
Lilly updates prescribing information periodically based on research.
CIALIS is not indicated for use in pediatric patients.
5.14 Consideration of Other Urological Conditions Prior to Initiating Treatment for BPH
CIALIS is not indicated for use in females. There is no information on the presence of tadalafil and/or metabolites in human milk, the effects on the breastfed child, or the effects on milk production. Tadalafil and/or its metabolites are present in the milk of lactating rats at concentrations approximately 2.4-fold greater than found in the plasma. Based on the data from 3 studies in adult males, tadalafil decreased sperm concentrations in the study of 10 mg tadalafil for 6 months and the study of 20 mg tadalafil for 9 months. This effect was not seen cialis tablet price in the study of 20 mg tadalafil taken for 6 months. Safety and efficacy in patients below the age of 18 years have not been established.
Cialis is a medication used primarily to treat erectile dysfunction (ED).
It contains the active ingredient tadalafil.
Cialis is produced by Eli Lilly and Company.
It works by relaxing muscles and increasing blood flow to certain areas.
Cialis can also treat symptoms of benign prostatic hyperplasia (BPH).
The effects of Cialis can last up to 36 hours.
It is available in various doses, including 2.5 mg, 5 mg, 10 mg, and 20 mg.
Cialis is taken orally, usually 30 minutes before sexual activity.
Common side effects include headache, flushing, and indigestion.
Cialis should not be combined with nitrates to avoid dangerous blood pressure drops.
It was first approved by the FDA in 2003.
Cialis can be prescribed for daily use or as needed.
A randomized, double-blind, placebo-controlled trial in pediatric patients (7 to 14 years of age) with Duchenne muscular dystrophy, who received CIALIS 0.3 mg/kg, CIALIS 0.6 mg/kg, or placebo daily for 48 weeks failed to demonstrate any benefit of treatment with CIALIS on a range of assessments of muscle strength and performance.
Cialis is sometimes combined with psychological counseling for ED.
Lifestyle factors, such as diet and exercise, can impact Cialis outcomes.
Lilly supports research into ED causes and therapies.
Psychological stress may reduce Cialis effectiveness.
Cialis’s long half-life allows for flexible timing of dosages.
Sexual partners may also benefit from understanding ED treatment.
Proper storage prevents Cialis degradation and loss of potency.
Research indicates Cialis may help vascular function overall.
Patient confidentiality is maintained during Cialis prescription.
Cialis is not a recreational drug; misuse can have health risks.
Regular health checks recommended for chronic Cialis users.
Patient testimonials often highlight increased quality of life.
No adverse effects were observed in a study in which tadalafil was administered orally at doses of 60, 200, and 1000 mg/kg/day to juvenile rats on postnatal days 14 to 90.
Product
Dosage
Quantity + Bonus
Price
Cialis Generic
20mg
10 Pills
31.49€ 29.99€
Cialis Super Active
20mg
90 + 10 Pills
314.14€ 299.18€
Cialis Generic
5mg
360 + 10 Pills
268.08€ 255.31€
Cialis Soft Tabs
20mg
20 + 2 Pills
66.98€ 63.79€
Cialis Generic
10mg
60 + 6 Pills
105.81€ 100.77€
Cialis Generic
2.5mg
180 + 10 Pills
154.86€ 147.49€
Cialis Soft Tabs
20mg
10 Pills
39.03€ 37.17€
Cialis Generic
5mg
120 + 6 Pills
132.92€ 126.59€
Cialis Original
20mg
64 + 4 Pills
274.18€ 261.12€
Cialis Generic
5mg
20 Pills
41.99€ 39.99€
The highest plasma tadalafil exposures (AUC) achieved were approximately 10-fold that observed at the MRHD.
Use Case
Description
Notes
Erectile Dysfunction (ED)
Improves ability to achieve/maintain erection
Most common use
Pulmonary Arterial Hypertension
Reduces blood pressure in lungs
Prescribed under different dose
Benign Prostatic Hyperplasia
Relieves urinary symptoms
Off-label use
Raynaud's Phenomenon
Relaxes blood vessels
Experimental treatment
Of the total number of subjects in ED clinical studies of tadalafil, approximately 19 percent were 65 and over, while approximately 2 percent were 75 and over.
6.2 Postmarketing Experience
Most, but not all, of these patients had underlying anatomic or vascular risk factors for development of NAION, including but not necessarily limited to: low cup to disc ratio ("crowded disc"), age over 50, diabetes, hypertension, coronary artery disease, hyperlipidemia, and smoking [see Warnings and Precautions (5.4)]. Otologic — Cases of sudden decrease or loss of hearing have been reported postmarketing in temporal association with the use of PDE5 inhibitors, including CIALIS. In some of the cases, medical conditions and other factors were reported that may have also played a role in the otologic adverse events. In many cases, medical follow-up information was limited. It is not possible to determine whether these reported events are related directly to the use of CIALIS, to the patient's underlying risk factors for hearing loss, a combination of these factors, or to other factors [see Warnings and Precautions (5.5)].
12.2 Pharmacodynamics
Urogenital — priapism [see Warnings and Precautions (5.3)]. Nitrates — Administration of CIALIS to patients who are using any form of organic nitrate, is contraindicated. In clinical pharmacology studies, CIALIS was shown to potentiate the hypotensive effect of nitrates. In a patient who has taken CIALIS, where nitrate administration is deemed medically necessary in a life-threatening situation, at least 48 hours should elapse after the last dose of CIALIS before nitrate administration is considered. In such circumstances, nitrates should still only be administered under close medical supervision with appropriate hemodynamic monitoring [see Dosage and Administration (2.7), Contraindications (4.1), and Clinical Pharmacology (12.2)].
7.1 Potential for Pharmacodynamic Interactions with CIALIS
Alpha-Blockers — Caution is advised when PDE5 inhibitors are coadministered with alpha-blockers. Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin, tamsulosin or alfuzosin. [see Dosage and Administration (2.7), Warnings and Precautions (5.6), and Clinical Pharmacology (12.2)]. Antihypertensives — PDE5 inhibitors, including tadalafil, are mild systemic vasodilators. Small reductions in blood pressure occurred following coadministration of tadalafil with these agents compared with placebo. Of the total number of subjects in BPH clinical studies of tadalafil (including the ED/BPH study), approximately 40 percent were over 65, while approximately 10 percent were 75 and over.
Study / Source
Effectiveness (%)
Comments
Clinical Trial 2022
70-80%
Used in men with ED
Patient Surveys
75%
Reported satisfaction with Cialis
Comparative Studies
Slightly better than Viagra
Longer duration of effect
Real-world Data
78%
Consistent effectiveness
In these clinical trials, no overall differences in efficacy or safety were observed between older (>65 and ≥75 years of age) and younger subjects (≤65 years of age).
Attribute
Description
Notes
Generic Name
Tadalafil
Main active ingredient
Brand Name
Cialis (by Lilly)
Commercial name
Dosage Forms
Tablets, oral
Available forms
Typical Dose
5 mg, 10 mg, 20 mg
Varies per prescription
Onset of Action
30-60 minutes
Time to effect
Duration of Effect
Up to 36 hours
Pharmacological window
However, in placebo-controlled studies with CIALIS for use as needed for ED, diarrhea was reported more frequently in patients 65 years of age and older who were treated with CIALIS (2.5% of patients) [see Adverse Reactions (6.1)]. No dose adjustment is warranted based on age alone.
12.3 Pharmacokinetics
Cytochrome P450 Inducers — Studies have shown that drugs that induce CYP3A4 can decrease tadalafil exposure. CYP3A4 (e.g., Rifampin) — Rifampin (600 mg daily), a CYP3A4 inducer, reduced tadalafil 10-mg single-dose exposure (AUC) by 88% and Cmax by 46%, relative to the values for tadalafil 10 mg alone. Although specific interactions have not been studied, other CYP3A4 inducers, such as carbamazepine, phenytoin, and phenobarbital, would likely decrease tadalafil exposure. The reduced exposure of tadalafil with the coadministration of rifampin or other CYP3A4 inducers can be anticipated to decrease the efficacy of CIALIS for once daily use; the magnitude of decreased efficacy is unknown. Cytochrome P450 Substrates — CIALIS is not expected to cause clinically significant inhibition or induction of the clearance of drugs metabolized by cytochrome P450 (CYP) isoforms.
8.3 Females and Males of Reproductive Potential
Studies have shown that tadalafil does not inhibit or induce P450 isoforms CYP1A2, CYP3A4, CYP2C9, CYP2C19, CYP2D6, and CYP2E1. Theophylline) — Tadalafil had no significant effect on the pharmacokinetics of theophylline. When tadalafil was administered to subjects taking theophylline, a small augmentation (3 beats per minute) of the increase in heart rate associated with theophylline was observed. Warfarin) — Tadalafil had no significant effect on exposure (AUC) to S-warfarin or R-warfarin, nor did tadalafil affect changes in prothrombin time induced by warfarin. CIALIS (tadalafil) is not indicated for use in females.
Indications and Usage for Cialis
There are no data with the use of CIALIS in pregnant women to inform any drug-associated risks for adverse developmental outcomes. In animal reproduction studies, no adverse developmental effects were observed with oral administration of tadalafil to pregnant rats or mice during organogenesis at exposures up to 11 times the maximum recommended human dose (MRHD) of 20 mg/day (see Data). Animal reproduction studies showed no evidence of teratogenicity, embryotoxicity, or fetotoxicity when tadalafil was given orally to pregnant rats or mice at exposures up to 11 times the maximum recommended human dose (MRHD) of 20 mg/day during organogenesis. In a prenatal/postnatal developmental study in rats, postnatal pup survival decreased following maternal exposure to tadalafil doses greater than 10 times the MRHD based on AUC. Signs of maternal toxicity occurred at doses greater than 16 times the MRHD based on AUC. However, a greater sensitivity to medications in some older individuals should be considered.
5.8 Hepatic Impairment
[see Warnings and Precautions (5.6) and Clinical Pharmacology (12.2)]. Alcohol — Both alcohol and tadalafil, a PDE5 inhibitor, act as mild vasodilators. Substantial consumption of alcohol (e.g., 5 units or greater) in combination with CIALIS can increase the potential for orthostatic signs and symptoms, including increase in heart rate, decrease in standing blood pressure, dizziness, and headache. Tadalafil did not affect alcohol plasma concentrations and alcohol did not affect tadalafil plasma concentrations. [see Warnings and Precautions (5.9) and Clinical Pharmacology (12.2)].
17.8 Sudden Hearing Loss
[See Dosage and Administration (2.7) and Warnings and Precautions (5.10)]. Nizatidine) — An increase in gastric pH resulting from administration of nizatidine had no significant effect on pharmacokinetics. Cytochrome P450 Inhibitors — CIALIS is a substrate of and predominantly metabolized by CYP3A4. Studies have shown that drugs that inhibit cialis buy cheap CYP3A4 can increase tadalafil exposure. CYP3A4 (e.g., Ketoconazole) — Ketoconazole (400 mg daily), a selective and potent inhibitor of CYP3A4, increased tadalafil 20 mg single-dose exposure (AUC) by 312% and Cmax by 22%, relative to the values for tadalafil 20 mg alone.
8.5 Geriatric Use
Ketoconazole (200 mg daily) increased tadalafil 10-mg single-dose exposure (AUC) by 107% and Cmax by 15%, relative to the values for tadalafil 10 mg alone [see Dosage and Administration (2.7)]. Although specific interactions have not been studied, other CYP3A4 inhibitors, such as erythromycin, itraconazole, and grapefruit juice, would likely increase tadalafil exposure. HIV Protease inhibitor — Ritonavir (500 mg or 600 mg twice daily at steady state), an inhibitor of CYP3A4, CYP2C9, CYP2C19, and CYP2D6, increased tadalafil 20-mg single-dose exposure (AUC) by 32% with a 30% reduction in Cmax, relative to the values for tadalafil 20 mg alone. Ritonavir (200 mg twice daily), increased tadalafil 20-mg single-dose exposure (AUC) by 124% with no change in Cmax, relative to the values for tadalafil 20 mg alone. Although specific interactions have not been studied, other HIV protease inhibitors would likely increase tadalafil exposure [see Dosage and Administration (2.7)]. In clinical pharmacology studies, tadalafil exposure (AUC) in subjects with mild or moderate hepatic impairment (Child-Pugh Class A or B) was comparable to exposure in healthy subjects when a dose of 10 mg was administered.
8.5 Geriatric Use
Surviving offspring had normal development and reproductive performance. In another rat prenatal and postnatal development study at doses of 60, 200, and 1000 mg/kg, a reduction in postnatal survival of pups was observed. The no observed effect level (NOEL) for maternal toxicity was 200 mg/kg/day and for developmental toxicity was 30 mg/kg/day. This gives approximately 16 and 10 fold exposure multiples, respectively, of the human AUC for the MRHD of 20 mg. Tadalafil and/or its metabolites cross the placenta, resulting in fetal exposure in rats.